There is no official Neuralink consumer list price.
Neuralink's N1 implant is currently available only through clinical research. The company has not published a retail sticker price for the device or surgery, and the implant is not sold commercially to the public.
According to Neuralink's PRIME Study Brochure, the devices used in the PRIME study are investigational and are not for sale.
The same brochure explains that Neuralink may cover study-related costs such as travel for participants. That support reimburses study expenses and is not a salary. Joining the patient registry is not a paid role.
Because the implant is not sold commercially, the practical path for eligible people is clinical trial participation rather than buying a consumer device.
Neuralink reported 21 participants ("Neuralnauts") on January 28, 2026. Neura Pod's patient table counted 27+ publicly identified patients as of June 2026. The implant is not sold to the public; access is through Neuralink's clinical trials and patient registry.
The public count can differ from Neuralink's official count because not every participant is publicly named.
If you or someone you care for may be eligible, start with Neuralink's official trials page and patient registry:
Apply or join the Neuralink Patient Registry
Neuralink screens applicants against study criteria. Neuralink has not announced a date for FDA approval of commercial sales.
No. There is no official consumer list price. PRIME devices are investigational and not for sale.
No. Study-related costs such as travel may be covered.
No. The implant is not sold commercially.
Use Neuralink's official page: neuralink.com/trials.